by Steven Grossman | Mar 12, 2025 | Short Takes and Updates
If you have not signed up to receive the FDA Matters newsletter in your email box, go to the home page to sign up. On Monday, I had the honor to address the annual meeting of America’s Blood Centers (ABC). It reminded me how much I learn by preparing for speeches and...
by Steven Grossman | Mar 7, 2025 | Uncategorized
DOGE claims $30M savings from canceling 30 FDA leasesThe Department of Government Efficiency (DOGE) this week claimed it had canceled 30 leases for US Food and Drug Administration (FDA) facilities nationwide, including a facility in St. Louis, MO, which is crucial to...
by Steven Grossman | Mar 7, 2025 | Short Takes and Updates
If you have not signed up to receive the FDA Matters newsletter in your email box, go to the home page to sign up. 1. Taken From This Week’s Headlines Elon Musk learns there is a Budget Control Act protocol, known as recissions, for cutting appropriated funding....
by Steven Grossman | Mar 4, 2025 | Short Takes and Updates
If you have not signed up to receive the FDA Matters newsletter in your email box, go to the home page to sign up. President Trump nominated Johns Hopkin Professor Martin Makary to be the next Commissioner of FDA. His confirmation hearing is Thursday, March 6 at 10...
by Steven Grossman | Feb 27, 2025 | Short Takes and Updates
LIVE EVENT!Come join us tomorrow, (Friday, February 28) at 11 a.m. ET to discuss the need for a regulatory pathway to enable the development of products that extend the span of life free of chronic diseases and...
